FY2023 EPS Estimates for STERIS’ (TSE:STE) Boosted by Analyst

STERIS’ (TSE:STEGet Rating) – Investment analysts at Cormark lifted their FY2023 earnings per share estimates for STERIS’ in a research note issued on Friday, September 16th. Cormark analyst B. Watson now expects that the company will earn $1.49 per share for the year, up from their prior estimate of $1.41.

STERIS’ (TSE:STEGet Rating) last posted its quarterly earnings data on Wednesday, August 10th. The company reported C$0.54 earnings per share for the quarter, beating analysts’ consensus estimates of C$0.20 by C$0.34. The company had revenue of C$273.00 million for the quarter, compared to analysts’ expectations of C$252.87 million.

STERIS’ Price Performance

About STERIS’

(Get Rating)

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.

Further Reading

Earnings History and Estimates for STERIS’ (TSE:STE)

Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.